共 442 条
[1]
Adams S(2014)Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 J Clin Oncol 32 2959-2966
[2]
Gray RJ(1997)Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective study Breast Cancer Res Treat 43 7-14
[3]
Demaria S(2012)Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies Cancer Treat Rev 38 708-714
[4]
Goldstein L(2016)Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression Genome Biol 17 218-5125
[5]
Perez EA(2016)Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis Oncoimmunology 5 e1061176-70
[6]
Shulman LN(2005)Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients J Clin Oncol 23 5117-991
[7]
Martino S(2012)Comprehensive molecular portraits of human breast tumours Nature 490 61-5165
[8]
Wang M(2015)Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without Carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers J Clin Oncol 33 983-947
[9]
Jones VE(2008)Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes Clin Cancer Res 14 5158-2004
[10]
Saphner TJ(2012)Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial Breast Cancer Res Treat 131 939-33318